Qube Research & Technologies (QRT)’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$131K Sell
700
-3,300
-83% -$607K ﹤0.01% 2984
2026
Q1
$755K Sell
4,000
-9,200
-70% -$1.94M ﹤0.01% 2613
2025
Q4
$2.62M Sell
13,200
-100
-0.8% -$20.2K ﹤0.01% 2131
2025
Q3
$2.7M Buy
+13,300
New +$2.36M ﹤0.01% 2088
2025
Q2
Sell
-3,200
Closed -$430K 3972
2025
Q1
$430K Buy
3,200
+3,100
+3,100% +$408K ﹤0.01% 2594
2024
Q4
$12.6K Buy
+100
New +$14.9K ﹤0.01% 3223

Other funds holding THC

Qube Research & Technologies (QRT)'s THC Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Tenet Healthcare (THC) stake by 89% in Q2 2026, selling an estimated $107M and leaving 72,008 shares worth $13.5M. The position accounts for 0.01% of the portfolio, ranked #1118.

Qube Research & Technologies (QRT) first reported a position in THC in Q2 2018 and has held it in 18 quarters since. The position peaked at $178M in Q4 2024. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Qube Research & Technologies (QRT) held 72,008 shares of Tenet Healthcare worth $13.5M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 581,324 Tenet Healthcare shares in Q2 2026, an estimated $107M.
  • Tenet Healthcare made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1118 holding.
  • Qube Research & Technologies (QRT) first reported a position in Tenet Healthcare in Q2 2018 and has held it in 18 quarters since.
  • Qube Research & Technologies (QRT)'s Tenet Healthcare position peaked at $178M in Q4 2024.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.